ArticleBrain connectivity2021
Resting-State Functional Connectivity Disruption as a Pathological Biomarker in Autosomal Dominant Alzheimer Disease.
Open access · greenAbstract read
In one paragraph
Article in Brain connectivity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 27 citations in OpenAlex.
- Iron accumulation in the substantia nigra is linked to functional network connectivity alterations in early-stage Parkinson's Disease: an exploratory study.NPJ Parkinson's disease · 2026Article
- Functional network collapse in neurodegenerative disease.Nature communications · 2025Article
- Investigating the Aβ and tau pathology in autosomal dominant Alzheimer's disease: insights from hybrid PET/MRI and network mapping.Alzheimer's research & therapy · 2025Article
- Basal forebrain global functional connectivity is preserved in asymptomatic presenilin-1 E280A mutation carriers: Results from the Colombia cohort.The journal of prevention of Alzheimer's disease · 2025Article
- Concurrent optoacoustic tomography and magnetic resonance imaging of resting-state functional connectivity in the mouse brain.Nature communications · 2024Article
- Investigation of hemispheric asymmetry in Alzheimer's disease patients during resting state revealed BY fNIRS.Scientific reports · 2024Article
- Edge time series components of functional connectivity and cognitive function in Alzheimer's disease.Brain imaging and behavior · 2024Article
- Functional network disruption in cognitively unimpaired autosomal dominant Alzheimer's disease: a magnetoencephalography study.Brain communications · 2024Article
- Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer's disease.Network neuroscience (Cambridge, Mass.) · 2024Article
- Edge Time Series Components of Functional Connectivity and Cognitive Function in Alzheimer's Disease.medRxiv : the preprint server for health sciences · 2023Article
- Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer disease.bioRxiv : the preprint server for biology · 2023Article
- MRAβ: A multimodal MRI-derived amyloid-β biomarker for Alzheimer's disease.Human brain mapping · 2023Article
- Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN).Nature neuroscience · 2023Article
- Brain network decoupling with increased serum neurofilament and reduced cognitive function in Alzheimer's disease.Brain : a journal of neurology · 2023Article
- Alterations via inter-regional connective relationships in Alzheimer's disease.Frontiers in human neuroscience · 2023Article
- Predicting brain age from functional connectivity in symptomatic and preclinical Alzheimer disease.NeuroImage · 2022Article
- Neuroimaging Modalities in Alzheimer's Disease: Diagnosis and Clinical Features.International journal of molecular sciences · 2022Review
- Amyloid-β and tau pathologies relate to distinctive brain dysconnectomics in preclinical autosomal-dominant Alzheimer's disease.Proceedings of the National Academy of Sciences of the United States of America · 2022Article
- Age-Related Changes in Functional Connectivity during the Sensorimotor Integration Detected by Artificial Neural Network.Sensors (Basel, Switzerland) · 2022Article
- Resting state network mapping in individuals using deep learning.Frontiers in neurology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
31 authors at 11 institutions in 3 countries.
Robert X SmithDepartment of Neurology, Washington University in Saint Louis, St. Louis, Missouri, USA.
Jeremy F StrainDepartment of Neurology, Washington University in Saint Louis, St. Louis, Missouri, USA.
Aaron TanenbaumDepartment of Neurology, Washington University in Saint Louis, St. Louis, Missouri, USA.
Anne M FaganDepartment of Neurology, Washington University in Saint Louis, St. Louis, Missouri, USA.
Jason HassenstabDepartment of Neurology, Washington University in Saint Louis, St. Louis, Missouri, USA.
Eric McDadeDepartment of Neurology, Washington University in Saint Louis, St. Louis, Missouri, USA.
Suzanne E SchindlerDepartment of Neurology, Washington University in Saint Louis, St. Louis, Missouri, USA.
Brian A GordonDepartment of Radiology, Washington University in Saint Louis, St. Louis, Missouri, USA.
Chengjie XiongDepartment of Biostatistics, Washington University in Saint Louis, St. Louis, Missouri, USA.
Jasmeer ChhatwalDepartment of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Clifford JackDepartment of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
Celeste KarchHope Center for Neurological Disorders, Knight ADRC, Washington University, St. Louis, Missouri, USA.
Sarah BermanDepartment of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Jared R BroschDepartment of Neurology, Indiana University, Indianapolis, Indiana, USA.
James J LahDepartment of Neurology, Emory University, Atlanta, Georgia, USA.
Adam M BrickmanDepartment of Neurology, Columbia University, New York, New York, USA.
David M CashDepartment of Neurodegenerative Disease, Dementia Research Centre, Institute of Neurology, University College London, London, United Kingdom.
Nick C FoxDepartment of Neurodegenerative Disease, Dementia Research Centre, Institute of Neurology, University College London, London, United Kingdom.
Neill R Graff-RadfordDepartment of Neurology, Mayo Clinic, Jacksonville, Florida, USA.
Johannes LevinGerman Center for Neurodegenerative Disease (DZNE) Munich, Munich, Germany.
James NobleDepartment of Neurology, Columbia University, New York, New York, USA.
David M HoltzmanDepartment of Neurology, Washington University in Saint Louis, St. Louis, Missouri, USA.
Colin L MastersThe Florey Institute, University of Melbourne, Parkvile, Australia.
Martin R FarlowDepartment of Neurology, Indiana University, Indianapolis, Indiana, USA.
Christoph LaskeEberhard Karls University of Tubingen, Tubingen, Germany.
Peter R SchofieldNeuroscience Research Australia and School of Medical Sciences, The University of New South Wales (UNSW) Sydney, Sydney, Australia.
Daniel S MarcusDepartment of Radiology, Washington University in Saint Louis, St. Louis, Missouri, USA.
John C MorrisDepartment of Neurology, Washington University in Saint Louis, St. Louis, Missouri, USA.
Tammie L S BenzingerDepartment of Radiology, Washington University in Saint Louis, St. Louis, Missouri, USA.
Randall J BatemanDepartment of Neurology, Washington University in Saint Louis, St. Louis, Missouri, USA.
Beau M AncesDepartment of Neurology, Washington University in Saint Louis, St. Louis, Missouri, USA.
Washington University in St. Louis · USColumbia University · USIndiana University – Purdue University Indianapolis · USUniversity College London · GBEmory University · USGerman Center for Neurodegenerative Diseases · DEMassachusetts General Hospital · USMayo Clinic · USMayo Clinic in Florida · USUniversity of Pittsburgh · USUniversity of Tübingen · DE
Funding
WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8MSmartphone-Based "Burst" Cognitive AssessmentsP01AG003991 · NIA · WASHINGTON UNIVERSITY · PI Suzanne Elizabeth Schindler · 1985 to 2026
$69.5MImaging CoreU19AG032438 · NIA · WASHINGTON UNIVERSITY · PI BATEMAN, RANDALL J · 2010 to 2025
$53.9MWASHINGTON UNIVERSITY ALZHEIMERS DISEASE RESEARCH CENTERP50AG005681 · NIA · WASHINGTON UNIVERSITY · PI MORRIS, JOHN · 1985 to 2019
$52.1MThe natural history of AB accumulation in preclinical ADP01AG026276 · NIA · WASHINGTON UNIVERSITY · PI MORRIS, JOHN · 2005 to 2025
$49.5MResearch Education ComponentP30AG066444 · NIA · WASHINGTON UNIVERSITY · PI Andrea Denny · 2020 to 2026
$28.7MDominantly Inherited Alzheimer NetworkUF1AG032438 · NIA · WASHINGTON UNIVERSITY · PI BATEMAN, RANDALL J · 2014 to 2017
$21.6MPET Imaging of Neuroinflammation in Genetic Alzheimer's DiseaseR01AG052550 · NIA · WASHINGTON UNIVERSITY · PI Beau M Ances, Tammie Lee Smith Benzinger · 2018 to 2026
$4.2MFALLS: A MARKER OF PRECLINICAL ALZHEIMERS DISEASER01AG057680 · NIA · WASHINGTON UNIVERSITY · PI ANCES, BEAU M, STARK, SUSAN LYNN · 2018 to 2022
$3.4MNEUROIMAGING AND NEUROBEHAVIORAL BASIS OF RISKY DECISION-MAKING IN ADOLESCENTSR01NR012907 · NINR · WASHINGTON UNIVERSITY · PI ANCES, BEAU M · 2011 to 2015
$1.9MTHE EFFECTS OF AGE AND HIGHLY ACTIVE ANTIRETROVIRAL THERAPY ON BRAIN FUNCTIONR01NR012657 · NINR · WASHINGTON UNIVERSITY · PI ANCES, BEAU M · 2010 to 2014
$1.9MNeuroimaging Markers of Emerging Dysfunction In Preclinical Alzheimer DiseaseK01AG053474 · NIA · WASHINGTON UNIVERSITY · PI GORDON, BRIAN ANDREW · 2017 to 2021
$623kNCATS NIH HHS UL1 TR002345NIA NIH HHS K01 AG053474NIA NIH HHS P01 AG003991NIA NIH HHS P01 AG026276NIA NIH HHS P30 AG066444NIA NIH HHS P50 AG005681NIA NIH HHS R01 AG052550NIA NIH HHS R01 AG057680NIA NIH HHS U19 AG032438NIA NIH HHS UF1 AG032438NINR NIH HHS R01 NR012657NINR NIH HHS R01 NR012907
Abstract
PubMed holds no abstract for this paper.
Indexed as
Alzheimer DiseaseAmyloid beta-PeptidesBiomarkersBrainCross-Sectional StudiesHumansMagnetic Resonance ImagingPositron-Emission TomographyAmyloid beta-PeptidesBiomarkers18F-fluorodeoxyglucose (FDG)amyloidautosomal dominant Alzheimer diseasecerebrospinal fluid (CSF)estimated years to onset (EYO)hippocampuspositron emission tomography (PET)resting-state functional connectivitytau
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.